GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
201 hedge funds and large institutions have $3.07B invested in Global Blood Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
201
Holders Change
+11
Holders Change %
+5.79%
% of All Funds
4.36%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.22%
New
31
Increased
63
Reduced
75
Closed
19
Calls
$83.1M
Puts
$30.2M
Net Calls
+$53M
Net Calls Change
-$2.13M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$31.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$24.4M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$17.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$11.1M |
Top Sellers
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$23.8M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$23.8M |
| 3 |
Citigroup
New York
|
-$11.2M |
| 4 |
TA
Teachers Advisors
New York
|
-$10.8M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.56M |
